Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Levin

Showing results (1-10 of 328) with videos related to

Pageof 33
Sort By:
Geriatrics|June 1, 1993
Osteoporosis: prevention is key to managementR M Levin
Journal of the American Geriatrics Society|June 1, 1987
Thyrotoxicosis in the elderlyR M Levin
Advances in Experimental Medicine and Biology|December 22, 1999
Overview of nerves and pharmacology in the bladderR M Levin
Hospital Practice (Office Ed.)|May 15, 1991
The prevention of osteoporosisR M Levin
Hospital Practice (Office Ed.)|June 15, 1986
Sick euthyroid syndromeR M Levin
Molecular and Cellular Biochemistry|December 29, 2000
Regulation of the activity of choline acetyl transferase by lipoic acidN Haugaard, R M Levin
Neuropharmacology|February 1, 1980
Inhibition by trifluoperazine of calmodulin-induced activation of ATPase activity of rat erythrocyteR M Levin, B Weiss
Advances in Cyclic Nucleotide Research|January 1, 1978
Mechanism for selectively inhibiting the activation of cyclic nucleotide phosphodiesterase and adenylate cyclase by antipsychotic agentsB Weiss, R M Levin
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1979
Selective binding of antipsychotics and other psychoactive agents to the calcium-dependent activator of cyclic nucleotide phosphodiesteraseR M Levin, B Weiss
Molecular Pharmacology|July 1, 1977
Binding of trifluoperazine to the calcium-dependent activator of cyclic nucleotide phosphodiesteraseR M Levin, B Weiss
Pageof 33

Showing results (1-10 of 328) with videos related to

Sort By:
Pageof 33
Geriatrics|June 1, 1993
Osteoporosis: prevention is key to managementR M Levin
Journal of the American Geriatrics Society|June 1, 1987
Thyrotoxicosis in the elderlyR M Levin
Advances in Experimental Medicine and Biology|December 22, 1999
Overview of nerves and pharmacology in the bladderR M Levin
Hospital Practice (Office Ed.)|May 15, 1991
The prevention of osteoporosisR M Levin
Hospital Practice (Office Ed.)|June 15, 1986
Sick euthyroid syndromeR M Levin
Molecular and Cellular Biochemistry|December 29, 2000
Regulation of the activity of choline acetyl transferase by lipoic acidN Haugaard, R M Levin
Neuropharmacology|February 1, 1980
Inhibition by trifluoperazine of calmodulin-induced activation of ATPase activity of rat erythrocyteR M Levin, B Weiss
Advances in Cyclic Nucleotide Research|January 1, 1978
Mechanism for selectively inhibiting the activation of cyclic nucleotide phosphodiesterase and adenylate cyclase by antipsychotic agentsB Weiss, R M Levin
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1979
Selective binding of antipsychotics and other psychoactive agents to the calcium-dependent activator of cyclic nucleotide phosphodiesteraseR M Levin, B Weiss
Molecular Pharmacology|July 1, 1977
Binding of trifluoperazine to the calcium-dependent activator of cyclic nucleotide phosphodiesteraseR M Levin, B Weiss
Pageof 33